Research and Evaluation, incorporating ASERNIP-S


Find a surgeon

The Find a Surgeon directory is a listing of active Fellows of the Royal Australasian College of Surgeons who meet the requirements of the College's Continuing Professional Development (CPD) Program and have opted to be on the list. This list excludes retired or inactive Fellows.


Horizon scanning

Horizon scanning reports provide a background on a new and emerging health technology and present the evidence available pertaining to its safety and efficacy, which can be assessed as a basis of deciding if the technology should be further assessed, monitored or if no further assessment required. When a technology has a considerable evidence base and considered to be of substantial impact a review of approximately 30-40 pages is performed.

Our recent horizon scanning reports are provided below. Contact us to discuss your needs to find out whether we can assist you with similar products.

Developments in Surgical Practice













Technology Briefs conducted on behalf of the Health Policy Advisory Committee on Technology (HealthPACT)

Hysterectomy, endometrial ablation and hormone-releasing intrauterine devices for heavy menstrual bleeding, June 2017.

Sutureless aortic valve replacement in patients with severe aortic valve stenosis Update, March 2017.

Endovascular arteriovenous fistula creation systems, March 2017.

Monarch external trigeminal nerve stimulation for drug-refractory epilepsy, March 2017.

Endobronchial valves for patients with advanced heterogenous emphysema Update, March 2017.

Barricaid prosthesis for partial annulus replacement Update, March 2017.

STAR tumour ablation system Update, March 2017.

Bioresorbable vascular scaffolds for coronary artery disease (Update), December 2016.

Resuscitative endovascular balloon occlusion of the aorta (REBOA), December 2016.

Wireless left ventricular pacing without coronary sinus, December 2016.

Argus II retinal prosthesis, August 2016.

LINX reflux management system, August 2016.

An enhanced recovery after surgery program for hip and knee arthroplasty, August 2016.

BioZorb - an implantable device to delimit surgical site after lumpectomy in breast cancer, August 2016.

Ovation iX abdominal stent graft system, August 2016.

Ga-68 prostate specific membrane antigen (PSMA) PET/CT (nomination from SA and Vic), August 2016.

SureFire precision chemoembolization Infusion system keeps drugs within liver tumours, August 2016.

CT to reduce negative appendectomy rates, August 2016.

MicroVisualase thermal therapy system: MRI-guided laser ablation of neurologic tumourswave ablation for liver tumours, April 2016.

SentiMag® and Sienna+® system for sentinel lymph node biopsy in breast cancer, April 2016.

Non-invasive open ventilation system, April 2016.

Radiofrequency ablation for treating nasal hypertrophy of the inferior turbinates, April 2016.

STAR tumour ablation system, December 2015.

Microwave ablation for liver tumours, December 2015.

Mitral valve transapical approach, December 2015.

MRIdian™ system for MRI-guided radiotherapy, July 2015.

Vagus nerve blocking and gastric artery embolisation for obesity, July 2015.

The RePneu® Coil System and other bronchoscopic lung volume reduction treatments for advanced emphysema, July 2015.

Basic fibroblast growth factor (b-FGF) for the treatment of tympanic membrane perforation, July 2015.

PleurX® catheter system for the treatment of malignant pleural effusion, July 2015.

ROX Coupler for treatment-resistant hypertension, March 2015.

ZIO® XT Patch for diagnosis of cardiac arrhythmia, March 2015.

InSpace™ biodegradable subacromial spacer for rotator cuff tears, March 2015.

Barricaid® prosthesis for partial annulus replacement, March 2015.

Ablative techniques for the treatment of localised prostate cancer, November 2014.

Theralite™ for renal failure in patients with multiple myeloma, November 2014.

LeGoo® endovascular gel for the temporary occlusion of blood vessels during surgery, November 2014.

Sutureless aortic valve replacement in patients with severe aortic valve stenosis, November 2014.

New and emerging orthopaedic technologies in the Australian and New Zealand public health services, November 2014.

Microbial sealant to reduce surgical site infections following cardiac surgery, November 2014.

Neonatal screening for lysosomal storage disorders, November 2014.

Miethke proSA® adjustable gravitational shunt for hydrocephalus, July 2014.

Drug eluting stents with CD34 antibodies for the treatment of coronary artery disease, July 2014.

Remote presence robots in telemedicine, July 2014.

Implantable carotid sinus baroreflex device for the treatment of drug-resistant hypertension (Update), July 2014.

Online programs for weight loss, February 2014.

SentiMag® and Sienna+® for sentinel lymph node localisation in breast cancer, February 2014.

HPV OncoTect™ E6, E7 mRNA assay to guide colposcopy referral in cervical cancer screening, February 2014

Balloon sinuplasty for chronic rhinosinusitis (Update), February 2014.

Bilateral bone-anchored hearing aid (BAHA) implantation for bilateral hearing loss, November 2013.

Argus II® retinal prosthesis system for peripheral retinal degeneration, November 2013.

RePneu® lung volume reduction coils for patients with advanced emphysema, November 2013.

IRay® for wet age-related macular degeneration, November 2013.

Single-incision mini-sling system for female stress urinary incontinence, August 2013.

Magnetic resonance thermometry-guided laser interstitial thermal therapy for intracranial neoplasms, August 2013.

AIGISRx® antibacterial envelope for preventing infection in implanted cardiac devices, August 2013.

LINX® reflux management system for the treatment of gastro-oesophageal reflux, August 2013.

Microwave ablation for hepatic tumours, May 2013.

Multi-catheter interstitial brachytherapy for early stage breast cancer, May 2013.

Endoscopic pancreatic stenting for prophylaxis of pancreatic fistula after distal ancreatectomy, May 2013.

Sternum support vests to prevent sternal dehiscence, May 2013.

MGuard™: novel mesh covered bare metal stent, May 2013.

An essay to identify biopsy-negative prostate cancer, February 2013.

Antibiotics versus appendectomy for uncomplicated appendicitis, February 2013.

Margin Probe® to assess surgical margins during lumpectomy for breast cancer, February 2013.

Cardiovascular magnetic resonance (CMR) for the diagnosis of coronary heart disease, February 2013.

Inert liquid-to-solid gels for prostate-rectum separation during prostate radiation therapy, February 2013.

High-sensitivity troponin assay for the diagnosis of myocardial infarction, February 2013.

Biodegradable stents, February 2013.

EyeOP1®: ophthalmic high intensity focussed ultrasound for gaucoma, February 2013.

External aortic root support in Marfan syndrome, November 2012.

Pulse oximetry for detecting heart defects in newborns, November 2012.

Autologous blood injection for soft tissue injury, November 2012.

Basic fibroblast growth factor (b-FGF) for the treatment of tympanic membrane perforation, November 2012.

Robotic-assisted lung resection, November 2012.

SpyGlass® direct visualization system, November 2012.

EndoBarrier® gastrointestinal liner for obesity, November 2012.

Sutureless aortic valve replacement in patients with severe aortic valve stenosis, August 2012.

Neonatal screening for lysosomal storage disorders, August 2012.

Columbia Suicide Severity Rating Scale, August 2012.

Intravitreal corticosteroid implant for the treatment of diabetic macular oedema, August 2012.

Health Buddy® for telehealth patients, August 2012.

LifeStent® vascular stent for symptomatic lesions of the superficial femoral or proximal popliteal artery, August 2012.

Microbial sealant to reduce surgical site infections following coronary artery bypass graft, August 2012.

Hypoglossal nerve stimulation for sleep apnoea, August 2012.

Exalenz BreathID® breath test device for the diagnosis of liver disease, August 2012.

The Sapien™ and Sapien XT™ transcatheter aortic valve implantation (TAVI) devices for the treatment of symptomatic aortic valve stenosis, August 2012.

Pleurx® catheter system for the treatment of malignant pleural effusion, August 2012.

LeGoo®: reverse thermosensitive polymer gel for the temporary occlusion of blood vessels during surgery, May 2012.

Tumour treating fields for glioblastoma multiforme, May 2012.

Drug-eluting stents and balloons for the treatment of peripheral vascular disease, May 2012.

Near-infrared spectroscopy (NIRS) for monitoring of paediatric patients at risk of low perfusion following cardiac surgery, February 2012.

Theralite™ for treatment of renal failure in patients with multiple myeloma, February 2012.

Carillon mitral contour system for mitral regurgitation, February 2012.

Cerecyte (bioactive) coils for the treatment of intracranial aneurysms, February 2012.

Percutaneous pulmonary valve implantation, February 2012.

Natural orifice transluminal endoscopic surgery (NOTES): cholecystectomy, February 2012.

Balloon sinuplasty for chronic rhinosinusitis, February 2012.

Implantable carotid sinus baroreflex device for treatment of drug resistant hypertension (update), November 2011.

Percutaneous venoplasty for the treatment of chronic cerebrospinal venous insufficiency (CCSVI) in multiple sclerosis, November 2011.

Total artificial heart for end-stage refractory biventricular heart failure, November 2011.

Peptide receptor radionuclide therapy (PRRT) using somatostatin analogues to treat neuroendocrine tumours, August 2011.

High sensitivity troponin assays for the diagnosis of myocardial infarction, August 2011.

90Y Zevalin for the treatment of non-Hodgkin's lymphoma, August 2011.

Regional hyperthermia for soft-tissue sarcoma, August 2011.

Selective internal radiation therapy for the treatment of liver cancer, August 2011.

These reports are available from:

Horizon scanning reports conducted on behalf of the Australia and New Zealand Horizon Scanning Network (ANZHSN)

Prioritising summaries

Horizon scanning reports

These reports are available from:

Last update: 29-10-2018.